References
Original article
Drilon, A. et al. Repotrectinib in ROS1 fusion-positive non-small-cell lung cancer. N. Engl. J. Med. 390, 118–131 (2024)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. Repotrectinib effective in ROS1-fusion-positive NSCLC. Nat Rev Clin Oncol 21, 167 (2024). https://doi.org/10.1038/s41571-024-00864-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-024-00864-4
- Springer Nature Limited